500,000 eligible to benefit from new non-hormonal treatment for hot flushes caused by menopause
A new treatment option for menopausal hot flushes and night sweats can be used in the NHS when hormone replacement therapy (HRT) is not suitable Fezolinetant (Veoza*) is recommended to…
Thymidine Kinase 2 Deficiency (TK2d): European Commission approves doxecitine and doxribtimine (KYGEVVI®) as first and only treatment
UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that the European Commission (EC) has granted marketing authorization under exceptional circumstances for KYGEVVI (doxecitine and doxribtimine) for the treatment…
Cases of invasive meningococcal disease notified in Kent
The UK Health Security Agency is continuing to investigate an outbreak of meningococcal disease in Kent. As of 5pm on 19 March, 18 laboratory cases are confirmed and 11 notifications…
First-ever in-utero stem cell therapy for fetal spina bifida repair is safe. The Lancet
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat…
Exposing a hidden anchor for HIV replication
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. More than 40 million people worldwide live with AIDS…
Anxiety, gloom often accompany intellectual deficits
Adults with intellectual and developmental disabilities, such as autism and Down syndrome, experience substantially higher rates of anxiety and depression than the general population of adults, researchers reported in JAMA Network Open. The study, based on data…
New data on spontaneous coronary artery dissection (SCAD), a common cause of heart attacks in younger women
New insights into spontaneous coronary artery dissection – a devastating cause of heart attacks in young, healthy patients – were presented today at the EAPCI Summit 2026.1 The summit is…
Started within 48 hours of stroke, neuroprotective medication helped brain cells, recovery
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who received a…
Improving sleep isn’t enough: researchers highlight daytime function as key to assessing insomnia treatments
About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and irritability as well as increased health risks like diabetes and heart risks…
California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia,…